Evidence map›Paper›PMID 35806081›Full record

ReviewInternational journal of molecular sciences2022

Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Enrique González-Madrid, Ma Andreina Rangel-Ramírez, María José Mendoza-León, Oscar Álvarez-Mardones, Pablo A González, Alexis M Kalergis, Ma Cecilia Opazo, Claudia A Riedel

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Enrique González-MadridLaboratorio Endocrinología-Inmunología, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8320000, Chile.ORCID 0000-0003-1004-451X
Ma Andreina Rangel-RamírezLaboratorio Endocrinología-Inmunología, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8320000, Chile.
María José Mendoza-LeónLaboratorio Endocrinología-Inmunología, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8320000, Chile.ORCID 0000-0003-4760-7953
Oscar Álvarez-MardonesLaboratorio Endocrinología-Inmunología, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8320000, Chile.
Pablo A GonzálezMillennium Institute on Immunology and Immunotherapy, Santiago 8320000, Chile.ORCID 0000-0001-7709-6870
Alexis M KalergisMillennium Institute on Immunology and Immunotherapy, Santiago 8320000, Chile.ORCID 0000-0001-7622-5263
Ma Cecilia OpazoMillennium Institute on Immunology and Immunotherapy, Santiago 8320000, Chile.ORCID 0000-0003-4263-9294
Claudia A RiedelLaboratorio Endocrinología-Inmunología, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8320000, Chile.ORCID 0000-0003-0257-6751
Universidad Andrés Bello · CLPontificia Universidad Católica de Chile · CLUniversity of the Americas · CL

Funding

Agencia Nacional de Investigación y Desarrollo 11180739Agencia Nacional de Investigación y Desarrollo 1191300Agencia Nacional de Investigación y Desarrollo 21202085Agencia Nacional de Investigación y Desarrollo 21211419Agencia Nacional de Investigación y Desarrollo ICN09_16Andrés Bello University DI-03-19/N
6 · The paper itself

Abstract

Multiple sclerosis (MS) is an autoimmune disease characterized by a robust inflammatory response against myelin sheath antigens, which causes astrocyte and microglial activation and demyelination of the central nervous system (CNS). Multiple genetic predispositions and environmental factors are known to influence the immune response in autoimmune diseases, such as MS, and in the experimental autoimmune encephalomyelitis (EAE) model. Although the predisposition to suffer from MS seems to be a multifactorial process, a highly sensitive period is pregnancy due to factors that alter the development and differentiation of the CNS and the immune system, which increases the offspring's susceptibility to develop MS. In this regard, there is evidence that thyroid hormone deficiency during gestation, such as hypothyroidism or hypothyroxinemia, may increase susceptibility to autoimmune diseases such as MS. In this review, we discuss the relevance of the gestational period for the development of MS in adulthood.

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisAnimalsCentral Nervous SystemFemaleMyelin SheathPregnancyRisk Factorsexperimental autoimmune encephalomyelitisgestational periodhypothyroxinemiaimmune responsemultiple sclerosisrisk factorsthyroid hormones

Identifiers

PMID35806081
PMCPMC9266360
OpenAlexW4283513508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.